Abattis Bioceuticals Corp Stock Five Year Return
| ATTBF Stock | USD 0.0001 0.00 0.00% |
Abattis Bioceuticals Corp fundamentals help investors to digest information that contributes to Abattis Bioceuticals' financial success or failures. It also enables traders to predict the movement of Abattis Pink Sheet. The fundamental analysis module provides a way to measure Abattis Bioceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Abattis Bioceuticals pink sheet.
Abattis |
Abattis Bioceuticals Corp Company Five Year Return Analysis
Abattis Bioceuticals' Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
| Competition |
According to the company disclosure, Abattis Bioceuticals Corp has a Five Year Return of 0.0%. This indicator is about the same for the Pharmaceuticals average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Abattis Five Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Abattis Bioceuticals' direct or indirect competition against its Five Year Return to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Abattis Bioceuticals could also be used in its relative valuation, which is a method of valuing Abattis Bioceuticals by comparing valuation metrics of similar companies.Abattis Bioceuticals is currently under evaluation in five year return category among its peers.
Abattis Fundamentals
| Return On Equity | -0.28 | |||
| Return On Asset | -0.16 | |||
| Operating Margin | (10.96) % | |||
| Current Valuation | 4.08 M | |||
| Shares Outstanding | 477.8 M | |||
| Shares Owned By Institutions | 0.02 % | |||
| Price To Earning | (5.83) X | |||
| Price To Book | 0.38 X | |||
| Price To Sales | 1.33 X | |||
| Revenue | 356.88 K | |||
| Gross Profit | 241.34 K | |||
| EBITDA | (2.9 M) | |||
| Net Income | (3.04 M) | |||
| Cash And Equivalents | 2.4 M | |||
| Total Debt | 150.86 K | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 0.73 X | |||
| Book Value Per Share | 0.02 X | |||
| Cash Flow From Operations | 9.41 M | |||
| Earnings Per Share | (0.01) X | |||
| Number Of Employees | 32 | |||
| Beta | -60.6 | |||
| Market Capitalization | 473.03 K | |||
| Total Asset | 19.26 M | |||
| Retained Earnings | (10.13 M) | |||
| Working Capital | (588 K) | |||
| Current Asset | 260 K | |||
| Current Liabilities | 848 K | |||
| Z Score | 1.8 | |||
| Net Asset | 19.26 M |
About Abattis Bioceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Abattis Bioceuticals Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Abattis Bioceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Abattis Bioceuticals Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Abattis Pink Sheet
Abattis Bioceuticals financial ratios help investors to determine whether Abattis Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Abattis with respect to the benefits of owning Abattis Bioceuticals security.